Author Correction: Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes

Author Correction: Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes

Bibliographic Details
Main Authors:	Kalyani B. Karunakaran, Sanjeev Jain, Samir K. Brahmachari, N. Balakrishnan, Madhavi K. Ganapathiraju
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-03-01
Series:	Schizophrenia
Online Access:	https://doi.org/10.1038/s41537-024-00455-3

Similar Items

Parkinson’s disease and schizophrenia interactomes contain temporally distinct gene clusters underlying comorbid mechanisms and unique disease processes
by: Kalyani B. Karunakaran, et al.
Published: (2024-02-01)

Transcriptomics and weighted protein network analyses of the LRRK2 protein interactome reveal distinct molecular signatures for sporadic and LRRK2 Parkinson’s Disease
by: Yibo Zhao, et al.
Published: (2024-08-01)

Identification of distinct circulating exosomes in Parkinson's disease.
by: Tomlinson, P, et al.
Published: (2015)

Distinction between rhinitis alone and rhinitis with asthma using interactomics
by: Daniel Aguilar, et al.
Published: (2023-08-01)

Differential Cellular Interactome in Schizophrenia and Bipolar Disorder—Discriminatory Biomarker Role
by: Iván Menéndez-Valle, et al.
Published: (2023-11-01)

Distinctive Handwriting Signs in Early Parkinson’s Disease
by: Rosa Senatore, et al.
Published: (2022-12-01)

C. elegans Interactome; Human Binary Interactome; Rat Genome
by: K. Nybo, et al.
Published: (2008-11-01)

Unique characteristics of end-of-life hospitalizations in Parkinson disease
by: Whitley W. Aamodt, et al.
Published: (2023-10-01)

Benchmark Evaluation of Protein–Protein Interaction Prediction Algorithms
by: Brandan Dunham, et al.
Published: (2021-12-01)

Trichotillomania Comorbid with Schizophrenia
by: Othman, Zahiruddin, et al.
Published: (2019)

Deciphering the alteration of MAP2 interactome caused by a schizophrenia-associated phosphorylation
by: Jiali Lyu, et al.
Published: (2024-12-01)

Associations of motor and neuropsychiatric symptoms with comorbidities in prodromal Parkinson’s disease
by: Jia-Ru Chen, et al.
Published: (2024-11-01)

Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
by: Cheng Zhou, et al.
Published: (2024-01-01)

Distinctive interactomes of RNA polymerase II phosphorylation during different stages of transcription
by: Rosamaria Y. Moreno, et al.
Published: (2023-09-01)

Case report: Impact of hyperthyroidism on psychotic symptoms in schizophrenia comorbid with Graves’ disease
by: Yukiyoshi Sumi, et al.
Published: (2023-07-01)

Relative contribution of comorbid diseases to health-related quality of life in patients with Parkinson’s disease
by: Maija-Helena Keränen, et al.
Published: (2024-08-01)

Managing Bipolar Disease Complicated with Psychosis in Conjunction with Polypharmacy, Parkinson’s Disease, and Multiple Comorbidities
by: Ricardo Irizarry, et al.
Published: (2022-01-01)

Bioinformatics analysis of the potential receptor and therapeutic drugs for Alzheimer’s disease with comorbid Parkinson’s disease
by: Xuerong Zhou, et al.
Published: (2024-06-01)

The landscape of rare genetic variation associated with inflammatory bowel disease and Parkinson’s disease comorbidity
by: Meltem Ece Kars, et al.
Published: (2024-05-01)

Somatic comorbidities in patients with schizophrenia
by: N. Boussaid, et al.
Published: (2024-04-01)

Comorbid Medical Conditions in Schizophrenia
by: Betul Demirel Dongel, et al.
Published: (2017-09-01)

Comorbid anorexia nervosa and schizophrenia
by: C. De Andrés Lobo, et al.
Published: (2021-04-01)

Aligning Cross-Species Interactomes for Studying Complex and Chronic Diseases
by: Marianna Milano, et al.
Published: (2023-07-01)

Internal tremor in people with Parkinson’s Disease: Demographic characteristics and comorbid symptoms
by: Lana M. Chahine, et al.
Published: (2023-01-01)

INTERACTOMICS IN TRANSLATIONAL MEDICINE
by: A. I. Glukhov, et al.
Published: (2018-03-01)

Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson’s disease and atypical parkinsonism
by: Bradley J. Wilkes, et al.
Published: (2023-06-01)

Distinctive clinical and imaging trajectories in SWEDD and Parkinson’s disease patients
by: Cecilia Boccalini, et al.
Published: (2024-01-01)

Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
by: Cheng Zhou, et al.
Published: (2023-07-01)

Distinctive but not unique: the risks of psychedelic ethical exceptionalism
by: Cheung, K, et al.
Published: (2024)

The study of neurotropic autoantibody levels in patients with epilepsy, Parkinson’s disease and schizophrenia
by: M. V. Baturina, et al.
Published: (2018-02-01)

Parkinson's disease and comorbid myasthenia gravis: a case report and literature review
by: Qihao Zhang, et al.
Published: (2024-01-01)

Proteome-scale characterisation of motif-based interactome rewiring by disease mutations
by: Johanna Kliche, et al.
Published: (2024-07-01)

The Transglutaminase-2 Interactome in the APP23 Mouse Model of Alzheimer’s Disease
by: Micha M. M. Wilhelmus, et al.
Published: (2022-01-01)

Substance Use Disorder Comorbidity in Schizophrenia
by: Hatice İmer Aras
Published: (2013-09-01)

Lennox-Gastaut and Schizophrenia: Comorbidity or complication?
by: Z. Bencharfa, et al.
Published: (2022-06-01)

Brait-Fahn-Schwartz Disease: A Unique Co-Occurrence of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
by: Ayesha Aslam, et al.
Published: (2023-09-01)

Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson’s Disease
by: Asako Yoritaka, et al.
Published: (2022-01-01)

Editorial: Systems biology, women in science 2021/22: translational systems biology and in silico trials
by: Jane A. Leopold, et al.
Published: (2023-09-01)

Interactome of Arabidopsis Thaliana
by: Merve Yilmaz, et al.
Published: (2022-01-01)

Parkinson’s Disease-Related Brain Metabolic Pattern Is Expressed in Schizophrenia Patients during Neuroleptic Drug-Induced Parkinsonism
by: Ivan Kotomin, et al.
Published: (2022-12-01)